Patents-Review.com
ClassID:

96801 ⎘

C07K14/15 - CPC Classification

Classification description:

Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses; RNA viruses Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus human T-cell leukaemia-lymphoma virus

Sub-classes:
Recent Application in this class:
#1
20260146260
2026-05-28

Transduction of gammadelta T cells with pseudotyped retroviral vectors

 #2
20250147046
2025-05-08

NEW METHOD FOR IDENTIFYING HERV-DERIVED EPITOPES

 #3
20240197849
2024-06-20

Immunogenic compositions, antigen screening methods, and methods of generating immune responses

 #4
20240093233
2024-03-21

MEASLES-HIV OR MEASLES-HTLV VACCINE

 #5
20230312657
2023-10-05

ARC-BASED CAPSIDS AND USES THEREOF

 #6
20230099707
2023-03-30

PROTEIN-BASED PURIFICATION MATRICES AND METHODS OF USING THE SAME

 #7
20220389094
2022-12-08

Compositions and Methods for Treating Cancer with Anti-ROR1 Immunotherapy

 #8
20210371823
2021-12-02

METHOD FOR EXPANDING HUMAN DC CELL AND HUMAN DC CELL RESOURCE LIBRARY

 #9
20210308244
2021-10-07

Immunogenic compositions, antigen screening methods, and methods of generating immune responses

 #10
20210252068
2021-08-19

Fusion Fragment Chimeric Antigen Receptors and Uses Thereof

 #11
20200308258
2020-10-01

Anti-HERV-K envelope protein antibodies and methods for detecting HERV-K envelope protein in patients with sporadic amyotrophic lateral sclerosis

 #12
20200102385
2020-04-02

Compositions and methods for treating cancer with anti-ROR1 immunotherapy

 #13
20200033342
2020-01-30

Soluble and immunoreactive variants of HTLV capsid antigen P24

 #14
20190194278
2019-06-27

Immunostimulating peptides

 #15
20190085081
2019-03-21

CHIMERIC ANTIGEN RECEPTOR

 #16
20190055309
2019-02-21

Compositions and methods for treating cancer with anti-ROR1 immunotherapy

 #17
20180305666
2018-10-25

Methods for generating engineered human primary blood dendritic cell lines

 #18
20180221464
2018-08-09

Immunogenic compositions, antigen screening methods, and methods of generating immune responses

 #19
20180036401
2018-02-08

V1/V2 fragments of a HIV-1 envelope glycoprotein

 #20
20170334952
2017-11-23

Methods for the diagnosis of cancer through detection of human endogenous retrovirus WL (HERV-WL) envelope expression

 #21
20160331831
2016-11-17

Lentiviral vectors for generating immune responses against human T Lymphotrophic Virus Type 1

 #22
20150246111
2015-09-03

HIV-1 GP 120 V1/V2 antigens and immunological uses thereof

 #23
20150030623
2015-01-29

Recombinant feline leukemia virus vaccine containing optimized feline leukemia virus envelope gene

 #24
20130022632
2013-01-24

Recombinant feline leukemia virus vaccine containing optimized feline leukemia virus envelope gene

 #25
20110319593
2011-12-29

Process for the production of biologically active HIV-1 tat protein

 #26
20100135994
2010-06-03

Dendritic cell-specific antibody conjugate comprising anti-CD40 monoclonal antibodies conjugated to HIV-1 Gag/Nef